SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
M. D. Anderson Cancer Center Researchers Solve First Structure of a Key to Intact DNA Inheritance
December 24, 2007
 · 
1 min read
Lone Star Bio
Scoring System Identifies MDS Patients Who Appear to Have Low-Risk Disease but Actually Have a Poor Prognosis
December 24, 2007
 · 
1 min read
Lone Star Bio
Stem Cells Used to Fix Breast Defects
December 17, 2007
 · 
1 min read
Drug Development
Drug Combination Shrinks Breast Cancer Metastases in Brain, Dana-Farber Cancer Institute Study
December 17, 2007
 · 
1 min read
Drug Development
Herceptin Helps Women With Multiple Chromosomes Containing HER2 Gene, Study Finds
December 17, 2007
 · 
1 min read
Lone Star Bio
Survival Shortened When ER/PR Negative Breast Cancer Spreads to the Brain
December 17, 2007
 · 
1 min read
Lone Star Bio
Even Tiny Breast Tumors Can Be Aggressive and May Require Maximum Therapy
December 17, 2007
 · 
1 min read
Lone Star Bio
Fewer Breast Patients May Need Chemo
December 14, 2007
 · 
1 min read
Lone Star Bio
Gentler Chemotherapy Before Blood Stem Cell Transplant Causes Long-Term Complete Remission in Relapsed Follicular Lymphoma Patients, M. D. Anderson Cancer Center Study
December 12, 2007
 · 
1 min read
Lone Star Bio
UT Southwestern Medical Center: Patients with Mild Cushing Syndrome May Benefit from Adrenalectomy
December 12, 2007
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Medicenna Therapeutics Announces Key Program Updates and 2026 Outlook
January 16, 2026
 · 
11 min read
Press Releases
Gradalis’ Vigil® Demonstrates Significant Survival Benefit in cTMB-H / HRP Ovarian Cancer Patients; Phase 2b VITAL Trial Analysis Published in JCO – Precision Oncology
January 15, 2026
 · 
8 min read
Press Releases
Plus Therapeutics Announces Pricing of Upsized $15 Million Public Offering
January 15, 2026
 · 
5 min read
Press Releases
Moleculin Reports Independent Assessment Confirms No Cardiotoxicity of Annamycin in 90 Subjects
January 14, 2026
 · 
6 min read
Press Releases
Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
January 13, 2026
 · 
1 min read
Press Releases
Decoy Therapeutics Reaches Global Access Commitment Agreement to Focus on Development of a Globally Accessible, Scalable Peptide-Conjugate Manufacturing Platform
January 13, 2026
 · 
7 min read
Press Releases
Cassava Announces Publication of Peer-Reviewed Phase 3 Results for Simufilam in Alzheimer’s Disease in the Journal of Prevention of Alzheimer’s Disease
January 13, 2026
 · 
9 min read
Press Releases
TYBR Health Appoints Jeff Tyber to Board of Directors
January 13, 2026
 · 
2 min read
Press Releases
Tivic Delivers 200x Scale-up in Manufacturing for Lead Drug Candidate Entolimod(TM) And Achieves Reproducible Yields, Potency and Purity
January 13, 2026
 · 
6 min read
Press Releases
Caris Life Sciences Announces Preliminary Fourth Quarter and Full Year 2025 Results
January 13, 2026
 · 
7 min read
Load More